These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 2539504

  • 1. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.
    Fujinami RS, Rosenthal A, Lampert PW, Zurbriggen A, Yamada M.
    J Virol; 1989 May; 63(5):2081-7. PubMed ID: 2539504
    [Abstract] [Full Text] [Related]

  • 2. Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells.
    Zurbriggen A, Fujinami RS.
    J Virol; 1988 Oct; 62(10):3589-96. PubMed ID: 2843661
    [Abstract] [Full Text] [Related]

  • 3. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system.
    Zurbriggen A, Fujinami RS.
    J Virol; 1989 Apr; 63(4):1505-13. PubMed ID: 2538641
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment.
    Friedmann A, Frankel G, Lorch Y, Steinman L.
    J Virol; 1987 Mar; 61(3):898-903. PubMed ID: 3492612
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis.
    Yamada M, Zurbriggen A, Fujinami RS.
    J Exp Med; 1990 Jun 01; 171(6):1893-907. PubMed ID: 1693653
    [Abstract] [Full Text] [Related]

  • 6. Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant.
    Zurbriggen A, Yamada M, Thomas C, Fujinami RS.
    J Virol; 1991 Feb 01; 65(2):1023-30. PubMed ID: 1987366
    [Abstract] [Full Text] [Related]

  • 7. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype.
    Roos RP, Stein S, Routbort M, Senkowski A, Bodwell T, Wollmann R.
    J Virol; 1989 Oct 01; 63(10):4469-73. PubMed ID: 2476574
    [Abstract] [Full Text] [Related]

  • 8. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.
    Rodriguez M, Oleszak E, Leibowitz J.
    Crit Rev Immunol; 1987 Oct 01; 7(4):325-65. PubMed ID: 2827957
    [Abstract] [Full Text] [Related]

  • 9. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
    Clatch RJ, Lipton HL, Miller SD.
    J Immunol; 1986 Feb 01; 136(3):920-7. PubMed ID: 2416841
    [Abstract] [Full Text] [Related]

  • 10. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains.
    Clatch RJ, Lipton HL, Miller SD.
    Microb Pathog; 1987 Nov 01; 3(5):327-37. PubMed ID: 2849024
    [Abstract] [Full Text] [Related]

  • 11. Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease. The pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE.
    Barbano RL, Dal Canto MC.
    J Neurol Sci; 1984 Nov 01; 66(2-3):283-93. PubMed ID: 6085111
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of Theiler's virus-induced demyelination in nude mice.
    Rosenthal A, Fujinami RS, Lampert PW.
    Lab Invest; 1986 May 01; 54(5):515-22. PubMed ID: 3517486
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of Theiler's murine encephalomyelitis virus.
    Yamada M, Zurbriggen A, Fujinami RS.
    Adv Virus Res; 1991 May 01; 39():291-320. PubMed ID: 2038955
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures.
    Fujinami RS, Zurbriggen A, Powell HC.
    J Neuroimmunol; 1988 Nov 01; 20(1):25-32. PubMed ID: 2460501
    [Abstract] [Full Text] [Related]

  • 15. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.
    Nitayaphan S, Toth MM, Roos RP.
    J Virol; 1985 Feb 01; 53(2):651-7. PubMed ID: 2578578
    [Abstract] [Full Text] [Related]

  • 16. Antigenic variants are not selected during persistent infection with Theiler's virus.
    Leibowitz JL, Rodriguez M.
    Infect Immun; 1983 Jul 01; 41(1):440-2. PubMed ID: 6190757
    [Abstract] [Full Text] [Related]

  • 17. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin.
    Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R.
    J Immunol; 1993 Jul 01; 151(1):266-76. PubMed ID: 8326128
    [Abstract] [Full Text] [Related]

  • 18. Localization of a neutralization site of Theiler's murine encephalomyelitis viruses.
    Nitayaphan S, Toth MM, Roos RP.
    J Virol; 1985 Dec 01; 56(3):887-95. PubMed ID: 2415718
    [Abstract] [Full Text] [Related]

  • 19. Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus.
    Rodriguez M, Leibowitz JL, Powell HC, Lampert PW.
    Lab Invest; 1983 Dec 01; 49(6):672-9. PubMed ID: 6361374
    [Abstract] [Full Text] [Related]

  • 20. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.
    Cash E, Bandeira A, Chirinian S, Brahic M.
    J Immunol; 1989 Aug 01; 143(3):984-8. PubMed ID: 2545781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.